The Future of Oral Cancer Screening
A study sponsored by the National Cancer Institute and conducted by the University Of Miami Miller School Of Medicine has shown a new low-cost test to be accurate in early diagnosis of Head and Neck Squamous Cell Carcinoma. The product is being developed by Vigilant Biosciences and is expected to be launched late 2014 or early 2015.
According to Vigilant spokesperson Bill Wells,"The product is envisioned as a kit with a special oral rinse and test strip. The test strip detects certain proteins that are captured by the rinse and have been shown to be clinically associated as markers specific for oral cancer. The markers may be present before a lesion is easily visible with or without a visual screening aid and thereby allowing for earlier intervention than what is possible today. Early detection tests are needed because the majority of patients present in late stage when cure rates reach only 40%... a statistic that has not changed in the past 50 years."
More information on the science behind this test can be found at http://vigilantbiosciences.com/technology.html